{{Rsnum
|rsid=17779747
|Chromosome=17
|position=68494992
|Orientation=plus
|GMAF=0.1974
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 47.8 | 42.5 | 9.7
| HCB | 84.7 | 15.3 | 0.0
| JPT | 83.2 | 15.9 | 0.9
| YRI | 93.2 | 6.8 | 0.0
| ASW | 87.7 | 12.3 | 0.0
| CHB | 84.7 | 15.3 | 0.0
| CHD | 83.5 | 16.5 | 0.0
| GIH | 72.3 | 25.7 | 2.0
| LWK | 90.0 | 10.0 | 0.0
| MEX | 51.7 | 37.9 | 10.3
| MKK | 87.8 | 11.5 | 0.6
| TSI | 35.3 | 46.1 | 18.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19305409
|Trait=QT interval
|Title=Common variants at ten loci modulate the QT interval duration in the QTSCD Study
|RiskAllele=T
|Pval=6E-12
|OR=1.02
|ORtxt=[0.53-1.51] ms decrease
|OA=1
}}

{{PharmGKB
|RSID=rs17779747
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19305409; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Common variants at ten loci modulate the QT interval duration in the QTSCD Study. (Initial Sample Size: 15,842 individuals; Replication Sample Size: up to 13,602 individuals); (Region: 17q24.3; Reported Gene(s): KCNJ2; Risk Allele: rs17779747-T); (p-value= 0.000000000006).This variant is associated with QT interval.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164739901
}}

{{PMID|19305408|OA=1
}} Common variants at ten loci influence QT interval duration in the QTGEN Study.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs17779747
|overall_frequency_n=26
|overall_frequency_d=128
|overall_frequency=0.203125
|n_genomes=20
|n_genomes_annotated=0
|n_haplomes=22
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}